Blauvelt, A.; Langley, R. G.; Peris, K.; Silvestre, J. F.; Katoh, N.; Tauber, M.; Pinter, A.; Ameen, M.; Gooderham, M.; Øland, C. B.; Tindberg, A.-M.; Gjerum, L.; Reich, K. Continuous Tralokinumab Treatment over 4 Years in Adults With Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control. J of Skin 2024, 8, s376.